SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 84 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $23 | -100.0% | 26,360 | -67.9% | 0.00% | – |
| Q3 2022 | $129,000 | -21.8% | 82,204 | 0.0% | 0.00% | – |
| Q2 2022 | $165,000 | +108.9% | 82,204 | +122.8% | 0.00% | – |
| Q3 2019 | $79,000 | -20.2% | 36,894 | 0.0% | 0.00% | – |
| Q2 2019 | $99,000 | -43.4% | 36,894 | 0.0% | 0.00% | – |
| Q1 2019 | $175,000 | +96.6% | 36,894 | 0.0% | 0.00% | – |
| Q4 2018 | $89,000 | -45.1% | 36,894 | 0.0% | 0.00% | – |
| Q3 2018 | $162,000 | -39.1% | 36,894 | 0.0% | 0.00% | – |
| Q2 2018 | $266,000 | +40.0% | 36,894 | 0.0% | 0.00% | – |
| Q1 2018 | $190,000 | +35.7% | 36,894 | 0.0% | 0.00% | – |
| Q4 2017 | $140,000 | +122.2% | 36,894 | 0.0% | 0.00% | – |
| Q3 2017 | $63,000 | -39.4% | 36,894 | -28.9% | 0.00% | – |
| Q2 2017 | $104,000 | +160.0% | 51,889 | +408.4% | 0.00% | – |
| Q1 2017 | $40,000 | -48.7% | 10,206 | -36.3% | 0.00% | – |
| Q4 2016 | $78,000 | -61.4% | 16,015 | -38.5% | 0.00% | – |
| Q3 2016 | $202,000 | +38.4% | 26,050 | 0.0% | 0.00% | – |
| Q2 2016 | $146,000 | +4.3% | 26,050 | 0.0% | 0.00% | – |
| Q1 2016 | $140,000 | – | 26,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 15,001 | $1,410 | 0.00% |
| KLCM Advisors, Inc. | 20,000 | $1,880 | 0.00% |
| AlphaMark Advisors, LLC | 3,135 | $0 | 0.00% |
| TRUST CO OF VERMONT | 204 | $19 | 0.00% |
| SlateStone Wealth, LLC | 30,866 | $3 | 0.00% |
| Coppell Advisory Solutions LLC | 100 | $89 | 0.00% |
| Highlander Capital Management, LLC | 1,200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Russell Investments Group, Ltd. | 266 | $25 | 0.00% |
| OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,600 | $0 | 0.00% |